Insider buying last 90 days
No open-market insider purchases were filed for AFL in the last 90 days.
From Form 4 filings, dated to when each was filed.
AFLAC's stock this week centers on its third-quarter 2026 results, released 4 November, in which the company surpassed earnings and revenue estimates, compared with earnings of $2.49 per share a year ago. Coverage also flagged benefit ratios in the U.S. and Japan as a key focus for underwriting margins after a weaker prior quarter. Separately, a technical commentary piece described AFL as forming a breakout setup, citing a Technical Rating of 8 and a Setup Rating of 8, alongside outperformance against the market and peers. Additional stories marked the 25th anniversary of the company's Holiday Duck charitable program.
AFL closed at $125.30, up 1% on the day, sitting above both its 50-day average of $117.19 and 200-day average of $116.10, with the shorter average above the longer one. The GekkoIndex reads 45.5, placing the stock in the Neutral zone, down 3.8 over the prior five readings. Price stands 7% above Gekko Fair Value of $117.13. The stock trades within its 52-week range of $105.76 to $130.22, with one-month returns of 10.3% and one-year returns of 17.1%.
No confirmed earnings date appears on the calendar following the Q3 report issued 4 November. No insider, Congress, or unusual options activity is recorded in the current windows, and no billionaire holders are listed, though trailblazer holders stand at zero. Analyst views are split among 10 firms, with 2 buy, 5 hold, and 3 sell ratings, and a consensus target of $117.33. Seasonality over the next 20 trading days has averaged 1.2% across 5 years, rising in 4 of them.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
AFLAC scores 2 supportive, 1 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed1 headwind
Above 50 and 200-day
Close $125.30 is above the 50-day ($117.19) and 200-day ($116.10) averages, and the 50-day is above the 200-day.
See the chart45.5, Neutral
Reading 45.5 is in the Neutral zone.
See the GekkoIndex7.0% above
Price is 7% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyNo data
No confirmed report date on the calendar.
See earnings+1.2% on average
From this point in the calendar, the next 20 trading days averaged +1.2% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
AFLAC closed at $125.30 on Nov 4, 2026, +17.1% over the past year, inside a 52-week range of $105.76 to $130.22.
Use the left and right arrow keys to read daily values.
Put AFL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
AFLAC provides supplemental health and life insurance, offering policies that pay out alongside a person's main medical coverage rather than replacing it. It is widely known for its insurance products covering cancer, accidents, and other health events, sold to individuals and workplaces in Japan and the United States.
The company runs its business through two main divisions, Aflac Japan and Aflac U.S. The Japan division sells cancer, medical, and nursing-care income policies, along with the GIFT plan, whole and term life coverage, and savings products such as WAYS and child endowment plans. The U.S. division offers cancer, accident, short-term disability, critical illness, and hospital indemnity policies, plus dental, vision, long-term care, disability, and life insurance. These products reach customers through career sales agents, independent brokers, agencies, and affiliated partners.
AFLAC was founded in 1955 and is headquartered in Columbus, Georgia. Its shares are listed on the NYSE under the ticker AFL.
AFLAC’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 45.5, in the Neutral zone, down 3.8 points over five sessions.
Down 3.8 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 20 | +2.9% | +5.2% | ||
| Accumulation | 192 | +0.6% | +2.4% | ||
| Neutral (current zone) | 445 | +0.2% | +0.6% | ||
| Distribution | 31 | −0.3% | +2.8% | ||
| Selling | 9 | Too few readings yet | |||
Average AFL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
AFLAC trades 7.0% above Gekko Fair Value of $117.13, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what AFLAC shares are worth, recalculated every trading day.
$117.13
Gekko Fair Value, Nov 4, 2026
7.0% Overvalued
At the end of Aug 2026 the price was 3.1% below the estimate.
No open-market insider purchases were filed for AFLAC, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for AFL in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in AFL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
AFLAC has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold AFL.
AFLAC beat the EPS estimate in 4 of its last 8 reports, moving 4.3% on average across the report.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 29, 2026 | $1.75 est $1.80 | $4.35B est $4.20B | −2.3% |
| Feb 4, 2026 | $1.57 est $1.69 | $4.87B est $4.25B | +4.8% |
| Nov 4, 2025 | $2.49 est $1.77 | $4.79B est $4.37B | +4.0% |
| Aug 5, 2025 | $1.78 est $1.70 | $4.22B est $4.33B | +3.8% |
| Apr 30, 2025 | $1.66 est $1.67 | $3.45B est $4.28B | −4.7% |
| Feb 5, 2025 | $1.56 est $1.62 | $5.50B est $4.33B | −3.4% |
| Oct 30, 2024 | $2.16 est $1.68 | $3.04B est $4.30B | −4.7% |
| Jul 31, 2024 | $1.83 est $1.60 | $5.16B est $4.10B | +6.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for AFLAC is $117.33, −6.4% from the last close, from 10 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 10 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 15 | J.P. Morgan | $119 | −5.0% |
| Oct 12 | Piper Sandler | $138 | +10.1% |
| Oct 12 | Bank of America Securities | $133 | +6.1% |
| Oct 12 | Wells Fargo | $116 | −7.4% |
| Oct 8 | KBW | $120 | −4.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, AFLAC averaged +1.2% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.0% | 4 of 5 |
| Next 10 trading days | +3.1% | 4 of 5 |
| Next 15 trading days | +3.5% | 4 of 5 |
| Next 20 trading days | +1.2% | 4 of 5 |
| Next 30 trading days | +0.7% | 3 of 5 |
For scale, AFL’s typical 20-trading-day move in either direction is about 3.7%.
AFLAC’s market cap is $62.82B, with a P/E ratio of 13.4 and revenue of $18.07B over the last twelve months.
Coverage of AFLAC this week reads positive: 11 positive, 9 neutral and 2 negative headlines.
AFLAC’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGRProgressive | Neutral | 5.3% above |
| MFCManulife Financial | Neutral | 14.5% above |
| ALLAllstate | Neutral | 5.5% above |
| METMetLife | Neutral | 1.1% above |
| SLFSun Life Financial | Neutral | 11.2% above |
| AIGAIG | Neutral | 0.3% above |
A peer links to its own page where one exists.
AFLAC’s market cap is $62.82B at the Nov 4, 2026 close of $125.30, with 501.3M shares outstanding. The shares trade on a P/E ratio of 13.4.
The consensus analyst 12-month price target for AFLAC is $117.33, −6.4% from the last close. Of the 10 firms that rated the stock in the last 90 days, 2 rate it a buy, 5 a hold and 3 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate AFLAC is overvalued: the Nov 4, 2026 close of $125.30 is 7.0% above Gekko Fair Value of $117.13. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
AFLAC’s 52-week high is $130.22 and its 52-week low is $105.76; it closed at $125.30 on Nov 4, 2026, +17.1% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (trend and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.